Topic Highlight
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Jul 21, 2014; 20(27): 8998-9016
Published online Jul 21, 2014. doi: 10.3748/wjg.v20.i27.8998
Figure 1
Open in New Tab Full Size Figure Download Figure
Figure 1 World Health Organization global and regional implementation of universal hepatitis B vaccination at birth and screening of pregnant women plus hepatitis B immune globulin administration at birth. The data were drawn from the WHO “Global policy report on the prevention and control of viral hepatitis”[36]. HBIG: Hepatitis B immune globulin; HB: Hepatitis B.
Figure 2
Open in New Tab Full Size Figure Download Figure
Figure 2 World Health Organization-estimated global coverage rates for the BCG, DPT3, polio, MCV1, Hep3, and Hib3 vaccines in 2012. The data are from[47]. BCG: Bacille Calmette-Guérin; DPT3: Three-dose DTP; MCV1: Measles-containing vaccine; Hep3: Three-dose hepatitis B; Hib3: Three-dose Hib vaccine
Figure 3
Open in New Tab Full Size Figure Download Figure
Figure 3 World Health Organization-estimated global coverage and coverage in each WHO region for the universal 3-dose hepatitis B vaccine in 2000 and 2012.
Figure 4
Open in New Tab Full Size Figure Download Figure
Figure 4 Incidence of acute hepatitis B in northern European countries with selective vaccination (◆: Denmark; ■: Finland; ▲: Norway; ×: Sweden; ✳: United Kingdom). The data for 2006 and 2007 in the United Kingdom were not available.